NxStage Medical, Inc. — Revenue by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/29348390-eb24-40ec-b0f3-db146ecbcd8e/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $393.9M | 2017-01-01 – 2017-12-31 | evidence 0001333170-18-000002 |
| FY 2016 | $366.4M | 2016-01-01 – 2016-12-31 | evidence 0001333170-17-000005 |
| FY 2015 | $336.1M | 2015-01-01 – 2015-12-31 | evidence 0001333170-16-000025 |
| FY 2014 | $301.5M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-064412 |
| FY 2013 | $263.4M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-080178 |
| FY 2012 | $242.1M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-084320 |
| FY 2011 | $217.3M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-087622 |
| FY 2010 | $179.2M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-087622 |
| FY 2009 | $148.7M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-087622 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NxStage Medical, Inc. — all facts · Net Income · Operating Income